Citeline Podcasts
Un pódcast de Citeline
1359 Episodo
-
Gennova CEO Singh On India’s mRNA Vaccine, Using Tech Against Cancer, Potential Equity Partnering
Publicado: 27/7/2022 -
Global Self Care Trends With Johnson & Johnson’s Adam Ricciardone
Publicado: 25/7/2022 -
Scrip’s Five Must-Know Things – 25 July 2022
Publicado: 25/7/2022 -
Pink Sheet Podcast: Trial Diversity, More PTAB Issues, US FDA Controlled Substance Leader Elevated
Publicado: 22/7/2022 -
DCTs: The Future Of Remote Trials
Publicado: 22/7/2022 -
Speaking Of Medtech, Ep. 10: FDA’s TAP Pilot
Publicado: 21/7/2022 -
급변하는 제약바이오 시장, 새로운 M&A 물결이 시작되었나?
Publicado: 20/7/2022 -
Scrip’s Five Must-Know Things – 18 July 2022
Publicado: 19/7/2022 -
Citeline Podcast Special: The Shifting Landscape For Drugs And Devices Post-Roe v. Wade
Publicado: 15/7/2022 -
Pink Sheet Podcast: Novavax Gets EUA, Califf Sets US FDA Departure, Hemophilia Patients Want REMS
Publicado: 15/7/2022 -
Digital Health Roundup: Solutions For Heart, Loneliness; Diabetes Talks; Post-Roe Legal Advice
Publicado: 11/7/2022 -
Pink Sheet Podcast: New Drug Pricing Bill, Second Amylyx US FDA Adcom, Skipping A Makena Vote
Publicado: 8/7/2022 -
Citeline中国生物制药热门话题聊
Publicado: 8/7/2022 -
Podcast: BD’s Polen Pursues ‘True North’ Path To High-Value Growth
Publicado: 6/7/2022 -
3分で解説 世界のファーマ 第3回 国際進出を強める韓国企業たち
Publicado: 6/7/2022 -
Scrip’s Five Must-Know Things – 4 July 2022
Publicado: 4/7/2022 -
It’s Coming Home: ImmunoACT Advances Plans For Cut-Price CAR-T In India
Publicado: 30/6/2022 -
The Push For OTC Birth Control With Victoria Nichols
Publicado: 28/6/2022 -
Scrip’s Five Must-Know Things – 27 June 2022
Publicado: 27/6/2022 -
Medtech Monthly, Ep. 1: Quality Vs. Compliance
Publicado: 24/6/2022
Citeline places biopharma and medical device professionals, and those who focus on these industries, at the forefront of knowledge and insight, by providing the perfect combination of news and information together with penetrating insight and analysis. Citeline is a leader in the field of healthcare industry information.